![Bart van Rhijn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bart van Rhijn
Direttore Finanziario/CFO presso NANOBIOTIX
Patrimonio netto: - $ in data 30/06/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Enno Spillner | M | 55 | 10 anni | |
Laurent Lévy | M | 53 | 21 anni | |
Anne-Marie Graffin | F | 63 | 10 anni | |
Gary Phillips | M | 58 | 3 anni | |
Louis Kayitalire | M | 66 | 1 anni | |
Alain Herrera | M | 74 | 13 anni | |
Patrick Tricoli | M | - | 10 anni | |
Anne-Juliette Hermant | F | 51 | 5 anni | |
Brandon Owens | M | - | - | |
Margaret Galluzzi | F | - | 5 anni | |
Mariam Hamze | F | 41 |
Galderma International SAS
![]() Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | 6 anni |
Craig West | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Philippe Mauberna | M | 59 | 8 anni | |
Raffaele Baffa | M | 65 |
Servier Pharmaceuticals LLC
![]() Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company, based in Boston, MA, was founded in 1954. Servier Pharmaceuticals is committed to innovation and improving the lives of patients, their families, and caregivers. The company invests in research and development to address the unmet needs of patients, particularly in the areas of oncology, cardiovascular diseases, cancers, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. The company offers financial assistance to support patients, advocacy groups, and healthcare professionals. The company strives for transparency in clinical trials and research and development. Servier Pharmaceuticals aims to create a brighter future for all by providing life-saving treatments to a greater number of patients. The company actively seeks alliances, acquisitions, licensing deals, and partnerships to accelerate access to therapies. David K. Lee has been the CEO of the company since 2018. | 2 anni |
Leonard A. Farber | M | - | 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Francia | 14 | 93.33% |
Stati Uniti | 1 | 6.67% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Bart van Rhijn
- Contatti personali